跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.101) 您好!臺灣時間:2026/03/28 08:13
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:曾毓婷
研究生(外文):Yu-Ting Tseng
論文名稱:利用 mRNA 與 microRNA 表現量資料於表現型特異性調控程序之研究
論文名稱(外文):The study of phenotype-specific regulatory programs using mRNA and microRNA expression data
指導教授:廖宜恩廖宜恩引用關係劉俊吉
指導教授(外文):I-En LiaoChun-Chi Liu
口試委員:李克昭陳健尉陳惠文黃耀廷
口試委員(外文):Ker-Chau LiJ.W. ChenHuei-Wen ChenYao-Ting Huang
口試日期:2014-06-18
學位類別:博士
校院名稱:國立中興大學
系所名稱:資訊科學與工程學系
學門:工程學門
學類:電資工程學類
論文種類:學術論文
論文出版年:2014
畢業學年度:102
語文別:英文
論文頁數:52
中文關鍵詞:特定表現型調控因子小分子 RNAChIP-seq
外文關鍵詞:phenotype- specifictranscription factorsmicroRNAChIP-seq
相關次數:
  • 被引用被引用:0
  • 點閱點閱:380
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
試圖去了解基因與其功能之間的複雜關係 在生物研究中一直是主要的目標,,而近年來計算方法 (computational methods) 已經成為其中一種主要方法去解決這類問題 快速累積的基因表現量資料也促進了表現型特異性 (phenotype-specific),資料的分析。在本論文中,我們利用 mRNA 與 microRNA 表現量資料發展了不同的方法,對表現型特異性調控進行研究。

第一部分是研究特定表現型調控程序,並且使用三種不同的分析方法建構出一個資料庫。在過去幾十年來,基因表現量之分析已被廣泛地研究,提供大量的表現量數據,然而,由於轉錄因子的調控機制是在後轉錄階段進行,通常是難以從基因表現量之變異直接地辨識出標靶基因,但近幾年因實驗技術的進步,使得科學家已經可以透過 ChIP-seq 實驗,有系統地找出轉錄因子之標靶基因。因此,我們建構了一個特定表現型調控程序之資料庫,稱作DPRP(http://syslab.nchu.edu.tw/DPRP/),對於轉錄因子與基因表現量之資料,做有效率且整合性地分析,提供生物學家作為參考。DPRP提供了三種不同的演算法:Fisher’sExactTest、Kolmogorov–Smirnovtest、BASE(BindingAssociationwithSortedExpression)演算法,利用這些演算法對於基因表現量的分析應用,可以促進生物和臨床研究領域中,更多轉錄調控程序之新假說的建立。

第二部分是研究miRNA與標靶基因交互作用之資料,並且對miRTarBase資料庫進行功能提升。miRNA是一種非編碼(non-coding)的小分子RNA,它能夠對基因的表達進行負調控,藉此控制許多細胞之運作機制。而miRTarBase(http://mirtarbase.mbc.nctu.edu.tw/)是一個廣泛收集經實驗驗證之miRNA與標靶基因交互作用的資料庫。在此研究中,最重大之更新為提供miRNA-target網路關係圖及miRNA-target基因表現的功能。本研究對於miRTarBase進行幾個重大的更新,包括:(i)增加了10倍的miRNA-target相互作用資料()提供miRNA-target網路關係圖()提供miRNA-target之表現量資料()提供miRNA-target相關疾病資料(v)其他附加功能,如升級訊息之提示和錯誤報告/用戶回饋系統。


Understanding how to map genes to their function is a challenge problem in biology research. In recent years, computational methods have become one of the promising research approaches to resolve this problem. Rapid accumulation of gene expression data with phenotype information facilitates the investigation of phenotype-specific regulatory programs. In this dissertation, I develop several approaches to study phenotype-specific regulatory programs using mRNA and microRNA (miRNA) expression data.

First, a database of phenotype-specific regulatory programs that uses three different methods to identify the regulatory programs underlying gene expression profiles was developed. In recent decades, gene expression has been extensively studied, providing a large amount of expression data in public databases. Because transcription factor (TF) activity is often regulated at the post-transcriptional level, identification of the TFs responsible for gene expression changes directly based on their own expression is challenging. Recently, advances in technology have made it possible to perform experiments through the system to determine TF target genes. Therefore, we built a database of phenotype-specific regulatory programs (DPRP, http://syslab.nchu.edu.tw/DPRP/) to identify the regulatory programs underlying gene expression profiles derived from the integrative analysis of TF binding data and gene expression data. DPRP uses three methods: the Fisher’s exact test, Kolmogorov– Smirnov test, and BASE (Binding Association with Sorted Expression) algorithm. These algorithms integrate the application of gene expression data to generate new transcriptional regulatory program hypotheses in biological and clinical research.

Second, data integration of miRNA-target interactions (MTIs) and miRTarBase functional improvements are discussed. miRNAs are a non-coding small RNAs that negatively regulate gene-expression profiles. The miRTarBase database (http://mirtarbase.mbc.nctu.edu.tw/) provides the most current and comprehensive information regarding experimentally validated miRNA-target interactions. The current status and recent improvements of the database include (i) a ten-fold increase in miRNA-target interaction entries, (ii) introduction of a miRNA-target network, (iii) expression profiles of miRNAs and their target genes, (iv) miRNA target-associated disease data, and (v) additional utilities such as an upgrade reminder and an error reporting/user feedback system are reported.


摘 要 ............i
ABSTRACT ............iii
CONTENTS ............v
LIST OF TABLES ............vii
LIST OF FIGURES ............viii
CHAPTER 1 Introduction ............1
1.1 Whole-cell computational model ............1
1.2 Research goal ............1
1.3 Major contributions ............2
1.4 Organization of the dissertation ............3
CHAPTER 2 Background ............4
2.1 Phenotype-Specific Regulatory Programs ............4
2.1.1 Transcriptional regulation ............4
2.1.2 Methods for inferring the regulatory activity of TFs ............5
2.1.3 ChIP-chip and ChIP-seq data ............5
2.2 miRNA-Target Interactions (MTIs) ............6
2.2.1 MicroRNAs (miRNAs) ............6
2.2.2 Databases related to miRNAs ............8
2.2.3 Experimentally confirmed miRNA-target interactions ............9
CHAPTER 3 Phenotype-Specific Regulatory Programs Derived from Transcription Factor Binding Data ............10
3.1 Transcription Factor Binding Data ............10
3.1.1 Gene expression data ............10
3.1.2 Phenotype annotation of gene expression data ............11
3.1.3 ChIP-seq data............13
3.2 Algorithms of Phenotype-Specific Regulatory Programs ............13
3.2.1 Fisher''s exact test ............13
3.2.2 Kolmogorov-Smirnov test ............14
3.2.3 BASE algorithm ............14
3.3 Results ............15
3.3.1 Web interfaces ............15
3.3.2 Example applications............19
3.4 Discussion ............22
CHAPTER 4 An Information Resource for Experimentally Validated miRNA-Target Interactions ............23
4.1 Updated Database Content ............23
4.1.1 Experimental validation method–addition of the ''NGS'' support type ............26
4.1.2 miRNA target-associated diseases ............28
4.1.3 miRNA-target network ............28
4.1.4 Expression profile of miRNA and its target gene ............28
4.2 Results ............33
4.2.1 Enhanced interface ............33
4.3 Discussion ............35
CHAPTER 5 Conclusions and Future Works ............39
5.1 The Key Results ............39
5.2 Suggestions for Future Research ............40
REFERENCES ............41


1. Karr JR, Sanghvi JC, Macklin DN, Gutschow MV, Jacobs JM, Bolival B, Jr., Assad-Garcia N, Glass JI, Covert MW: A whole-cell computational model predicts phenotype from genotype. Cell 2012, 150(2):389-401.
2. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M et al: NCBI GEO: archive for functional genomics data sets--update. Nucleic acids research 2013, 41(Database issue):D991-995.
3. Calkhoven CF, Ab G: Multiple steps in the regulation of transcription-factor level and activity. The Biochemical journal 1996, 317 ( Pt 2):329-342.
4. Boulikas T: Phosphorylation of transcription factors and control of the cell cycle. Critical reviews in eukaryotic gene expression 1995, 5(1):1-77.
5. Ouyang J, Valin A, Gill G: Regulation of transcription factor activity by SUMO modification. Methods Mol Biol 2009, 497:141-152.
6. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM: Mining for regulatory programs in the cancer transcriptome. Nature genetics 2005, 37(6):579-583.
7. Tsai HK, Lu HH, Li WH: Statistical methods for identifying yeast cell cycle transcription factors. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(38):13532-13537.
8. Cheng C, Yan X, Sun F, Li LM: Inferring activity changes of transcription factors by binding association with sorted expression profiles. BMC bioinformatics 2007, 8:452.
9. Harbison CT, Gordon DB, Lee TI, Rinaldi NJ, Macisaac KD, Danford TW, Hannett NM, Tagne JB, Reynolds DB, Yoo J et al: Transcriptional regulatory code of a eukaryotic genome. Nature 2004, 431(7004):99-104.
10. Cheng C, Li LM, Alves P, Gerstein M: Systematic identification of transcription factors associated with patient survival in cancers. BMC genomics 2009, 10:225.
11. Johnson DS, Mortazavi A, Myers RM, Wold B: Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316(5830):1497-1502.
12. Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I, Zeitlinger J, Schreiber J, Hannett N, Kanin E et al: Genome-wide location and function of DNA binding proteins. Science 2000, 290(5500):2306-2309.
13. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R et al: Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489(7414):91-100.
14. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma''ayan A: ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 2010, 26(19):2438-2444.
15. Qin J, Li MJ, Wang P, Zhang MQ, Wang J: ChIP-Array: combinatory analysis of ChIP-seq/chip and microarray gene expression data to discover direct/indirect targets of a transcription factor. Nucleic acids research 2011, 39(Web Server issue):W430-436.
16. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
17. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
18. Kim VN: Small RNAs: classification, biogenesis, and function. Mol Cells 2005, 19(1):1-15.
19. Engels BM, Hutvagner G: Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006, 25(46):6163-6169.
20. Esteller M: Non-coding RNAs in human disease. Nature reviews Genetics 2011, 12(12):861-874.
21. Kuhn DE, Nuovo GJ, Terry AV, Jr., Martin MM, Malana GE, Sansom SE, Pleister AP, Beck WD, Head E, Feldman DS et al: Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. The Journal of biological chemistry 2010, 285(2):1529-1543.
22. Wang G, van der Walt JM, Mayhew G, Li YJ, Zuchner S, Scott WK, Martin ER, Vance JM: Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. American journal of human genetics 2008, 82(2):283-289.
23. Kozomara A, Griffiths-Jones S: miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic acids research 2011, 39(Database issue):D152-157.
24. Betel D, Wilson M, Gabow A, Marks DS, Sander C: The microRNA.org resource: targets and expression. Nucleic acids research 2008, 36(Database issue):D149-153.
25. Alexiou P, Vergoulis T, Gleditzsch M, Prekas G, Dalamagas T, Megraw M, Grosse I, Sellis T, Hatzigeorgiou AG: miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic acids research 2010, 38(Database issue):D137-141.
26. Cho S, Jang I, Jun Y, Yoon S, Ko M, Kwon Y, Choi I, Chang H, Ryu D, Lee B et al: MiRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Nucleic acids research 2013, 41(Database issue):D252-257.
27. Wang X: miRDB: a microRNA target prediction and functional annotation database with a wiki interface. Rna 2008, 14(6):1012-1017.
28. Hsu SD, Chu CH, Tsou AP, Chen SJ, Chen HC, Hsu PW, Wong YH, Chen YH, Chen GH, Huang HD: miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes. Nucleic acids research 2008, 36(Database issue):D165-169.
29. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of mammalian microRNA targets. Cell 2003, 115(7):787-798.
30. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS: MicroRNA targets in Drosophila. Genome biology 2003, 5(1):R1.
31. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M et al: Combinatorial microRNA target predictions. Nature genetics 2005, 37(5):495-500.
32. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R: Fast and effective prediction of microRNA/target duplexes. Rna 2004, 10(10):1507-1517.
33. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E: The role of site accessibility in microRNA target recognition. Nature genetics 2007, 39(10):1278-1284.
34. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N, Dalamagas T, Hatzigeorgiou AG: TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic acids research 2012, 40(Database issue):D222-229.
35. Xiao F, Zuo Z, Cai G, Kang S, Gao X, Li T: miRecords: an integrated resource for microRNA-target interactions. Nucleic acids research 2009, 37(Database issue):D105-110.
36. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q: An analysis of human microRNA and disease associations. PloS one 2008, 3(10):e3420.
37. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G, Liu Y: miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic acids research 2009, 37(Database issue):D98-104.
38. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM, Hatzigeorgiou AG: DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic acids research 2013, 41(Database issue):D239-245.
39. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D: Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007, 129(2):303-317.
40. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N: Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455(7209):58-63.
41. Bodenreider O: The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic acids research 2004, 32(Database issue):D267-270.
42. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, Barrell D, Zadissa A, Searle S et al: GENCODE: the reference human genome annotation for The ENCODE Project. Genome research 2012, 22(9):1760-1774.
43. Cheng C, Min R, Gerstein M: TIP: a probabilistic method for identifying transcription factor target genes from ChIP-seq binding profiles. Bioinformatics 2011, 27(23):3221-3227.
44. Pruitt KD, Tatusova T, Brown GR, Maglott DR: NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic acids research 2012, 40(Database issue):D130-135.
45. Essaghir A, Toffalini F, Knoops L, Kallin A, van Helden J, Demoulin JB: Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data. Nucleic acids research 2010, 38(11):e120.
46. Zhu M, Liu CC, Cheng C: REACTIN: regulatory activity inference of transcription factors underlying human diseases with application to breast cancer. BMC genomics 2013, 14:504.
47. Lin Z, Reierstad S, Huang CC, Bulun SE: Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer. Cancer research 2007, 67(10):5017-5024.
48. Kong SL, Li G, Loh SL, Sung WK, Liu ET: Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state. Molecular systems biology 2011, 7:526.
49. Xu C, Fu H, Gao L, Wang L, Wang W, Li J, Li Y, Dou L, Gao X, Luo X et al: BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia. Oncogene 2012.
50. Wilkinson-White L, Gamsjaeger R, Dastmalchi S, Wienert B, Stokes PH, Crossley M, Mackay JP, Matthews JM: Structural basis of simultaneous recruitment of the transcriptional regulators LMO2 and FOG1/ZFPM1 by the transcription factor GATA1. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(35):14443-14448.
51. Dweep H, Sticht C, Pandey P, Gretz N: miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. Journal of biomedical informatics 2011, 44(5):839-847.
52. Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, Darnell RB: CLIP identifies Nova-regulated RNA networks in the brain. Science 2003, 302(5648):1212-1215.
53. Chi SW, Zang JB, Mele A, Darnell RB: Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460(7254):479-486.
54. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, Rothballer A, Ascano M, Jr., Jungkamp AC, Munschauer M et al: Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141(1):129-141.
55. German MA, Pillay M, Jeong DH, Hetawal A, Luo S, Janardhanan P, Kannan V, Rymarquis LA, Nobuta K, German R et al: Global identification of microRNA-target RNA pairs by parallel analysis of RNA ends. Nature biotechnology 2008, 26(8):941-946.
56. German MA, Luo S, Schroth G, Meyers BC, Green PJ: Construction of Parallel Analysis of RNA Ends (PARE) libraries for the study of cleaved miRNA targets and the RNA degradome. Nature protocols 2009, 4(3):356-362.
57. Li YF, Zheng Y, Addo-Quaye C, Zhang L, Saini A, Jagadeeswaran G, Axtell MJ, Zhang W, Sunkar R: Transcriptome-wide identification of microRNA targets in rice. The Plant journal : for cell and molecular biology 2010, 62(5):742-759.
58. Karginov FV, Cheloufi S, Chong MM, Stark A, Smith AD, Hannon GJ: Diverse endonucleolytic cleavage sites in the mammalian transcriptome depend upon microRNAs, Drosha, and additional nucleases. Molecular cell 2010, 38(6):781-788.
59. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP: Expanding the microRNA targeting code: functional sites with centered pairing. Molecular cell 2010, 38(6):789-802.
60. Bracken CP, Szubert JM, Mercer TR, Dinger ME, Thomson DW, Mattick JS, Michael MZ, Goodall GJ: Global analysis of the mammalian RNA degradome reveals widespread miRNA-dependent and miRNA-independent endonucleolytic cleavage. Nucleic acids research 2011, 39(13):5658-5668.
61. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM et al: miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic acids research 2011, 39(Database issue):D163-169.
62. Khorshid M, Rodak C, Zavolan M: CLIPZ: a database and analysis environment for experimentally determined binding sites of RNA-binding proteins. Nucleic acids research 2011, 39(Database issue):D245-252.
63. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH: starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic acids research 2011, 39(Database issue):D202-209.
64. Anders G, Mackowiak SD, Jens M, Maaskola J, Kuntzagk A, Rajewsky N, Landthaler M, Dieterich C: doRiNA: a database of RNA interactions in post-transcriptional regulation. Nucleic acids research 2012, 40(Database issue):D180-186.
65. Kudla G, Granneman S, Hahn D, Beggs JD, Tollervey D: Cross-linking, ligation, and sequencing of hybrids reveals RNA-RNA interactions in yeast. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(24):10010-10015.
66. Helwak A, Kudla G, Dudnakova T, Tollervey D: Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153(3):654-665.
67. Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q, Bader GD: Cytoscape Web: an interactive web-based network browser. Bioinformatics 2010, 26(18):2347-2348.
68. Maertzdorf J, Weiner J, 3rd, Mollenkopf HJ, Bauer T, Prasse A, Muller-Quernheim J, Kaufmann SH: Common patterns and disease-related signatures in tuberculosis and sarcoidosis. Proceedings of the National Academy of Sciences of the United States of America 2012, 109(20):7853-7858.
69. Marques FZ, Campain AE, Tomaszewski M, Zukowska-Szczechowska E, Yang YH, Charchar FJ, Morris BJ: Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 2011, 58(6):1093-1098.
70. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B et al: Integrative genomic profiling of human prostate cancer. Cancer cell 2010, 18(1):11-22.
71. Zhou Y, Chen L, Barlogie B, Stephens O, Wu X, Williams DR, Cartron MA, van Rhee F, Nair B, Waheed S et al: High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(17):7904-7909.
72. Lionetti M, Biasiolo M, Agnelli L, Todoerti K, Mosca L, Fabris S, Sales G, Deliliers GL, Bicciato S, Lombardi L et al: Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma. Blood 2009, 114(25):e20-26.
73. Montes-Moreno S, Martinez N, Sanchez-Espiridion B, Diaz Uriarte R, Rodriguez ME, Saez A, Montalban C, Gomez G, Pisano DG, Garcia JF et al: miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood 2011, 118(4):1034-1040.
74. Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Sugihara K, Doki Y et al: Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clinical cancer research : an official journal of the American Association for Cancer Research 2012, 18(11):3054-3070.
75. Wang HW, Wu YH, Hsieh JY, Liang ML, Chao ME, Liu DJ, Hsu MT, Wong TT: Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC genomics 2010, 11:132.
76. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C et al: Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466(7306):632-636.
77. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Ronneberg JA, Johnsen H, Navon R, Rodland E et al: miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PloS one 2011, 6(2):e16915.
78. Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ et al: Integrative survival-based molecular profiling of human pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2012, 18(5):1352-1363.
79. Ezzie ME, Crawford M, Cho JH, Orellana R, Zhang S, Gelinas R, Batte K, Yu L, Nuovo G, Galas D et al: Gene expression networks in COPD: microRNA and mRNA regulation. Thorax 2012, 67(2):122-131.
80. Holliday CJ, Ankeny RF, Jo H, Nerem RM: Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells. American journal of physiology Heart and circulatory physiology 2011, 301(3):H856-867.
81. Liao X, Xue H, Wang YC, Nazor KL, Guo S, Trivedi N, Peterson SE, Liu Y, Loring JF, Laurent LC: Matched miRNA and mRNA signatures from a hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. Journal of cell science 2013.
82. Kim H, Lee G, Ganat Y, Papapetrou EP, Lipchina I, Socci ND, Sadelain M, Studer L: miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells. Cell stem cell 2011, 8(6):695-706.
83. Wang L, Oberg AL, Asmann YW, Sicotte H, McDonnell SK, Riska SM, Liu W, Steer CJ, Subramanian S, Cunningham JM et al: Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines. PloS one 2009, 4(6):e5878.


QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top